G1 Therapeutics, Inc.
CDK INHIBITORS
Last updated:
Abstract:
Compounds of Formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
Status:
Application
Type:
Utility
Filling date:
13 May 2020
Issue date:
3 Sep 2020